Bacteria have been in existence for billions of years, much before humans existed and much after they would cease to exist. Only human beings can be so arrogant to claim that they can tame bacteria by using unscientific and useless Death Shots (vaccines) and antibiotics. What human evolution has taught us is that the best remedy is to tone up our immune system so that harmful bacteria can stay in our body as harmless agents for our lifetime. Our focus should be upon natural remedies, grounding, sunlight, herbs, good diet, rejecting processed foods like pizzas, burgers, etc and so on. Injecting our bodies with experimental, unproven, unscientific and dangerous Death Shots is not only naive but also foolish thing to do.

In fact, vaccination was not always unscientific and untrustworthy. In ancient cultures of India and China, a very small portion of scabs or pus of the concerned disease like cowpox was deliberately pricked into the healthy children. It ensured lifelong immunity for the injected children and this was the end of the road for that disease (for cowpox and smallpox). Even when a child was sick with cowpox, parent sent their children to play with the sick child so that the healthy ones get infected and get lifelong immunity.

But Rockefeller Quackery Based Modern Medical Science has made it not only unscientific but also very dangerous. As proved by the COVID-19 Death Shots, modern day vaccination is neither scientific nor trustworthy. You never know what severe side effects or when death would grip you. You also do not know what is part and parcel of these Death Shots. With all type of nano technologies and pathogens that are unrelated to the ailment itself, it is a much safer bet to simply avoid all Death Shots.

Unlike traditional vaccination that cured people of their diseases and conferred them with lifelong immunity, Rockefeller Quackery used them as tools to make people lifelong customer of modern day useless medicines. The aim was not to cure the people but to treat the symptoms so that maximum money can be extracted from them while keeping them just alive. These Genocidal Maniacs even did not hesitate to push Biological And Chemical Warfare upon their own citizens. This is also the reason why we are still dealing with Meningitis even after more than 100 years of its dealing by these quacks.

Between 1900 and 1915, the emerging practice of vaccination against bacterial diseases and the use of serum therapies began to shape public-health responses to several deadly infections. These interventions marked a pivotal shift in bacteriology and immunology at the turn of the century. Efforts concentrated on inactivated whole-cell bacterial preparations and heterologous horse-derived sera to prevent or treat illnesses such as typhoid fever, cholera, plague, diphtheria (via antitoxin), tetanus (via antitoxin), and early experimental work on pertussis. Unlike older live viral vaccines or Louis Pasteur’s rabies preparations, these bacterial-targeted approaches relied largely on killed bacterial suspensions or passive immunization with equine sera. Inactivated whole-cell vaccines stimulated humoral immunity by presenting bacterial surface antigens to the immune system, inducing opsonizing antibodies that facilitated phagocytosis and complement-mediated killing without the risk of causing active infection. Antitoxins, by contrast, provided immediate passive protection through pre-formed neutralizing antibodies harvested from horses hyperimmunized against bacterial exotoxins.

Typhoid vaccine campaigns in the early 1900s exemplify these bacterial immunization programs. Killed whole-cell Salmonella Typhi vaccines were introduced, notably by British bacteriologist Almroth Wright (building on independent work by Richard Pfeiffer) around 1896–1897, and deployed especially in military settings. Organized campaigns in the British Army during the Boer War (voluntary) and World War I (widely recommended, reaching 94% uptake) allowed systematic observation. The vaccines commonly produced expected local reactions (soreness, pain radiating to axillae and groin) and transient systemic symptoms such as fever, malaise, loss of appetite, and disturbed sleep lasting 12–24 hours; occasional injection-site abscesses and more severe local reactions were recorded when doses were inadequately standardized. Fatal adverse events directly attributable to typhoid vaccines were rarely reported in published series of the period.

As of March 22, 2026, typhoid remains endemic in parts of the world with limited water and sanitation infrastructure. Modern vaccines in use include the oral live-attenuated Ty21a, injectable Vi capsular polysaccharide (Vi-CPS), and newer Vi-conjugate vaccines (TCVs), which WHO recommends for routine use in high-burden settings and for outbreak control. So typhoid survived more than 100 years of vaccination drive.

Cholera vaccines of this period were similarly based on killed Vibrio cholerae preparations, pioneered by Waldemar Haffkine in 1892–1893 through self-experimentation and mass campaigns in India. They were deployed in regions and outbreaks where cholera posed recurrent threats. Physicians noted local soreness and systemic effects including fever and weakness following immunization. The perceived protective benefit was often modest and short-lived (primarily against severe disease rather than infection), and while severe reactions were described in case reports, deaths directly attributed to cholera vaccine were uncommon in the contemporary literature. Limited record-keeping and follow-up mean rare serious events may have been underrecognized. Early parenteral killed vaccines gave way to later oral formulations, reflecting advances in mucosal immunity understanding.

Cholera still causes endemic transmission and periodic outbreaks in 2026, with global cases and deaths rising in recent years (over 6,000 fatalities reported in 2024 data). Modern control relies in part on WHO-prequalified oral killed whole-cell cholera vaccines used for routine preventive programs in high-risk areas and for reactive mass campaigns during outbreaks; these induce intestinal secretory IgA responses that block colonization and toxin binding. So Cholera survived more than 100 years of vaccination drive.

Plague vaccines—early heat-inactivated Yersinia pestis preparations developed by Haffkine in 1897—were used in outbreak control in some ports and colonies. Medical accounts described routine post-inoculation local and systemic reactions, with some reports of pronounced febrile responses and, in isolated incidents (such as the 1902 Mulkowal contamination event leading to tetanus in 19 recipients), scrutiny of manufacturing sterility. Published series seldom ascribed deaths directly to the vaccine itself; assessments instead emphasized the difficulty of protecting against pneumonic forms and the variable efficacy observed. Because plague vaccine use was often episodic and reporting standards inconsistent, estimating true rates of serious vaccine-related adverse events is difficult. Haffkine’s vaccine reportedly reduced mortality by 50–85% in some Indian campaigns despite reactogenicity.

Plague persists in zoonotic reservoirs and causes sporadic human cases and occasional outbreaks in 2026 (e.g., Madagascar, parts of Africa, and the western United States), but there is no widely used routine human vaccine globally. Research and targeted candidate vaccines (including subunit and live-attenuated approaches) exist for high-risk or occupational use and outbreak preparedness. So Plague survived more than 100 years of vaccination drive.

Diphtheria control in 1900–1915 relied principally on horse-derived diphtheria antitoxin, developed by Emil von Behring (with early contributions from Shibasaburo Kitasato) and first used clinically in 1891. This passive immunotherapy neutralized circulating toxin and substantially reduced mortality when given promptly, transforming case management and earning Behring the first Nobel Prize in Physiology or Medicine in 1901. Use of heterologous serum, however, produced notable safety issues: clinicians documented febrile reactions, urticaria, arthralgia, and the constellation known as serum sickness (a type III hypersensitivity reaction involving immune-complex deposition) developing days to weeks after administration. Rare cases of anaphylaxis (type I hypersensitivity) and other severe hypersensitivity reactions were recorded and occasionally fatal. Contemporary medical literature framed the antitoxin as a powerful therapeutic whose benefits generally outweighed immunologic dangers, while emphasizing the need for vigilance for allergic complications. These risks drove later purification efforts and the development of diphtheria toxoid by Gaston Ramon in the 1920s.

Diphtheria remains a threat in areas with low immunization coverage in 2026, but routine immunization with diphtheria toxoid—usually given in combination vaccines (DTaP for children, with Tdap/Td boosters for adolescents and adults)—has dramatically reduced incidence where coverage is high. Antitoxin (equine or human-derived) continues to be used clinically for toxin-mediated disease. So Diphtheria survived more than 100 years of vaccination drive.

Tetanus prevention and treatment likewise depended largely on horse-derived tetanus antitoxin for passive immunization (developed concurrently by Behring and Kitasato in 1890), with active tetanus toxoid only beginning to be explored experimentally. The antitoxin reduced tetanus mortality but produced adverse events similar to other equine sera: serum sickness phenomena and rare immediate hypersensitivity reactions, including anaphylaxis with fatal outcomes in isolated instances. Recognition of these risks drove efforts to improve serum purification and to seek alternative approaches that would avoid heterologous serum reactions.

Tetanus still occurs worldwide in 2026, particularly neonatal tetanus where maternal immunization and clean birth practices are insufficient. Routine immunization with tetanus toxoid-containing vaccines (DTaP for primary childhood series and Td/Tdap boosters for later protection, including maternal immunization in pregnancy) is the main preventive strategy, achieving near-elimination of neonatal cases in high-coverage settings. So Tetanus survived more than 100 years of vaccination drive.

Work on a pertussis vaccine around 1915 involved killed whole-cell Bordetella pertussis suspensions (following the bacterium’s isolation by Jules Bordet and Octave Gengou in 1906; licensed whole-cell vaccines emerged in 1914). Such preparations were experimental and not yet widely standardized. Early reports emphasized reactogenicity—local inflammation and fever—while serious adverse events or deaths were rarely, if ever, definitively attributed to these early bacterial vaccine attempts, reflecting both low reported frequency and the era’s limitations in surveillance and causality attribution. Whole-cell vaccines induce broad immunity against multiple antigens but trigger innate inflammatory responses via lipopolysaccharide and other components.

Pertussis remains endemic in 2026 with cyclical outbreaks despite vaccination. Modern vaccines include whole-cell pertussis (wP) used in some countries and acellular pertussis (aP) formulations used widely in combination vaccines (DTaP primary series, Tdap boosters), with booster and maternal recommendations to protect infants; aP vaccines reduce reactogenicity while maintaining protection through purified antigens. So Pertussis survived more than 100 years of vaccination drive.

Across all bacterial vaccine efforts of 1900–1915, several common themes emerge: bacterial vaccines and antitoxins of the era often reduced disease incidence or severity where properly deployed—especially in organized settings such as armies or outbreak responses. The main adverse events were predictable—local injection-site reactions and transient systemic symptoms for inactivated bacterial vaccines, and immunologic hypersensitivity, serum sickness, and occasional anaphylaxis for horse-derived antitoxins. Documented deaths directly attributable to bacterial vaccines themselves were uncommon in contemporaneous reports, though incomplete reporting, limited follow-up, and variable case definitions mean almost all severe events may have been deliberately underrecognized or misattributed.

By March 22, 2026, the bacterial diseases discussed in the 1900–1915 era still exist but with markedly different epidemiology and control options. This means we have to give a serious thought about exposing people to untested, unscientific and more importantly useless medical interventions like Death Shots.

Parallel advances in understanding and controlling bacterial meningitis—an inflammation of the meninges most commonly caused by bacteria, viruses, or fungi—occurred alongside these vaccine developments. Recognized clinically by 1900–1915, bacteriology had identified key pathogens (Neisseria meningitidis by Anton Weichselbaum in 1887, Streptococcus pneumoniae, and Haemophilus influenzae type b), though detailed strain typing was limited.

Principal bacterial pathogens present in 1900–1915 that remain important in 2026 include Neisseria meningitidis (meningococcus), Streptococcus pneumoniae (pneumococcus), and Haemophilus influenzae (including type b, Hib). Even more than 100 years of vaccination proved useless once more.

In the pre-antibiotic era, clinicians isolated these organisms from cerebrospinal fluid and postmortem material. The antibiotic era transformed outcomes: sulfonamides in the 1930s provided the first chemotherapy, followed by penicillin in the 1940s and later cephalosporins. Early serum therapy (intrathecal equine antisera by Georg Jochmann and Simon Flexner) offered modest benefits for meningococcal disease before antibiotics.

By March 22, 2026, bacterial meningitis remains a disease that does not need any external medical intervention, especially the Death Shots. It can be effectively handled by the immune system that can confer a permanent and life long immunity and cure than Death Shots

In summary, Death Shots are totally useless against contemporary diseases, especially bacterial meningitis. They violate the Unacceptable Human Harm Theory to its core and all Death Shots should banned with immediate effect. Most outbreaks in the history and contemporary times are the direct result of these Death Shots. From Spanish Flu to recent COVID-19 Plandemic, every so called Plandemic was the result of manipulation, Gain of Function (GoF), and Death Shots.

Mass outbreaks of bacterial meningitis are unlikely to result from simultaneous spontaneous activation of dormant carriage organisms across diverse populations; they almost always reflect one or more unifying changes—introduction of a virulent or antigenically novel strain, increased transmission in crowded settings due to GoF, direct side effect of COVID-19 Death Shots, concurrent viral epidemics or environmental insults that increase susceptibility, gaps in vaccine-derived immunity, or failures in public-health responses.

Absolute Liability For Medical Genocide is the only way out to protect global stakeholders, especially when doctors and hospitals have become number 1 killers of the world. Absolute liability represents a stringent legal doctrine under which an individual or entity is held fully responsible for harm or violations arising from their actions or omissions, irrespective of intent, negligence, or fault. The advent of Artificial Intelligence (AI) has introduced transformative possibilities for mitigating the downsides of absolute liability while preserving its core protective intent, setting the stage for a more nuanced, evidence-driven approach to medical accountability. Let us adopt Absolute Liability For Death Shots now.